Skip to main content
. 2020 Oct 15;30(4):426–434. doi: 10.1002/pds.5124

FIGURE 4.

FIGURE 4

Percentage individual NOAC use among patients with NVAF by study year. Data are from two clinical benefit providers (Salud Total and Compensar). NOAC, non‐vitamin K antagonist oral anticoagulant; NVAF, nonvalvular atrial fibrillation [Colour figure can be viewed at wileyonlinelibrary.com]